ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.00%
US Tech 100
17,184.40
0.63%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.3663
-0.03%
Bitcoin
59,150.61
0.05%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vaxart Inc (VXRT)

  7. Vaxart Inc (VXRT) News

VXRT Vaxart Inc

0.74
-0.009 (-1.20%)
Pre Market
Last Updated: 06:14:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.009 -1.20% 0.74 06:14:01
Open Price Low Price High Price Close Price Previous Close
0.749
more quote information »

Recent News

Date Time Source Heading
4/30/202407:00GLOBEVaxart Announces Positive Results for Its Bivalent Norovirus..
3/27/202407:00GLOBEVaxart to Present at World Vaccine Congress Washington 2024..
3/20/202407:00GLOBEVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
3/14/202415:01GLOBEVaxart Provides Business Update and Reports Full Year 2023..
3/14/202406:41IHMARKETNEWSU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil..
3/07/202407:00GLOBEVaxart to Host Full Year 2023 Business Update and Financial..
3/06/202408:23EDGAR2Form 8-K - Current report
3/06/202407:00GLOBEVaxart, Inc. Appoints Steven Lo as President, Chief..
2/29/202415:30EDGAR2Form 8-K - Current report
2/15/202415:10EDGAR2Form 8-K - Current report
2/13/202416:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/05/202407:00GLOBEVaxart Announces Publication in Vaccines of Non-Human..
2/02/202415:49EDGAR2Form 8-K/A - Current report: [Amend]
1/19/202416:14EDGAR2Form 8-K - Current report
1/19/202415:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/19/202407:30GLOBEVaxart Receives $9.27 Million BARDA Project NextGen Award to..
1/16/202416:18EDGAR2Form 8-K - Current report
1/16/202408:25GLOBEVaxart Announces $10.0 Million Registered Direct Offering..
1/16/202408:22GLOBEVaxart, Inc. Announces Management Change
1/16/202408:19EDGAR2Form 8-K - Current report
12/21/202307:00GLOBEVaxart Announces Last Subject Dosed in Phase 1 Trial of Its..
11/02/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202315:11EDGAR2Form 8-K - Current report
11/02/202315:01GLOBEVaxart Provides Business Update and Reports Third Quarter..
11/02/202307:00GLOBEVaxart Doses First Subject in Phase 1 Trial of Its Norovirus..
10/26/202307:00GLOBEVaxart to Host Third Quarter 2023 Business Update and..
10/23/202316:09EDGAR2Form 8-K/A - Current report: [Amend]
10/23/202316:01EDGAR2Form 8-K - Current report
10/11/202307:00GLOBEVaxart to Present at World Vaccine Congress Europe 2023 on..
9/21/202307:00GLOBEVaxart to Participate in Fireside Chat at 2023 Cantor Global..
9/06/202315:43EDGAR2Form 8-K - Current report
9/06/202315:05GLOBEVaxart Announces Topline Data from the Phase 2 Challenge..
8/03/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202315:20EDGAR2Form 8-K - Current report
8/03/202315:01GLOBEVaxart Provides Business Update and Reports Second Quarter..
8/01/202320:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202320:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202320:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202320:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202319:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/27/202307:00GLOBEVaxart to Host Second Quarter 2023 Business Update and..
7/26/202315:20EDGAR2Form 8-K - Current report
7/10/202315:12EDGAR2Form 8-K - Current report
7/06/202307:00GLOBEVaxart Announces Positive Preliminary Topline Data from..
6/28/202315:22EDGAR2Form 8-K - Current report
6/26/202315:45GLOBEVaxart Stockholders Approve All Four Proposals in the 2023..
6/21/202315:30GLOBEVaxart Encourages All Stockholders of Record as of April 28,..
6/07/202308:16GLOBEVaxart, Inc. Announces Pricing of $15,000,000 Public..
6/06/202315:01GLOBEVaxart, Inc. Announces Proposed Public Offering of Common..
6/06/202307:00GLOBEVaxart Announces Last Subject Dosed in Phase 2 Trial of its..

Your Recent History

NASDAQ
VXRT
Vaxart
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved